uniQure (NASDAQ: QURE) electrified Wall Street this week, with shares surging nearly 200% after the company reportedly announced transformative clinical data for its Huntington’s disease gene therapy, AMT-130. The biotech, which just secured up to $175 million in non-dilutive funding, is riding…
Pfizer’s (PFE) move to acquire Metsera (Monday, Sept. 22, 2025) for up to $4.9 billion marks a pivotal expansion in the fast-evolving obesity and diabetes treatment market, intensifying the industry’s GLP-1 rivalry among major pharmaceutical players. Modular Medical (NASDAQ: MODD), with its…
GeoVax Labs, Inc. (NASDAQ: GOVX), an American clinical-stage biotechnology company, is advancing its Modified Vaccinia Ankara (MVA) vaccine platform, positioning itself as a key domestic alternative to Europe's Bavarian Nordic in addressing critical global health threats such as Mpox and smallpox. This…
The S&P 500’s historic ascent in 2025 is forcing market veterans to rethink old assumptions about the drivers of U.S. equities, as Wall Street strategists point to persistent profit growth, expanding margins, and the relentless pace of artificial intelligence investment as key…
Nuclear power is experiencing a global renaissance, rapidly transforming both market sentiment and energy infrastructure as it claims a central role in addressing the world’s surging electricity needs. Policymakers, investors, and tech giants alike now recognize atomic energy as a strategic asset,…
McDonald’s (MCD) has recently tapped seasoned executive Joe Erlinger to helm its expansive U.S. operations, marking a pivotal moment for the Golden Arches as it sharpens its strategies amid evolving economic and consumer dynamics. Erlinger’s appointment underscores the company’s enduring emphasis on…
Nvidia’s (NVDA) announcement of a $5 billion equity stake in Intel (INTC) marks a watershed moment for the global semiconductor industry, sending Intel shares surging over 25% and further fueling momentum in technology markets as investors reassess the embattled chipmaker’s future prospects.…
Roche’s headline-grabbing agreement to acquire 89bio (ETNB) in a deal valued at up to $3.5 billion marks a significant moment in the fast-evolving cardiometabolic and liver disease therapeutic sector, underscoring mounting competition for late-stage pipeline assets targeting Metabolic Dysfunction-Associated Steatohepatitis (MASH). As…
Waymo, Alphabet’s (GOOG) autonomous driving division, is deepening its push into commercial robotaxi operations through a new partnership with Lyft to launch driverless ride-hailing services in Nashville, Tennessee, beginning in 2026. In a joint announcement, the companies revealed that testing of Waymo’s…
Modular Medical (NASDAQ: MODD), a leader in innovative insulin delivery technology, is targeting the $3 billion adult “almost-pumpers” diabetes market with user-friendly, affordable patch pumps designed to simplify care for a population too often left behind by complex, expensive systems. Founded by…
